Steroids
Principles and Practice of Neurocritical Care, Page: 333-353
2024
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Neuroinflammation and cerebral edema are pivotal in the development of acute brain injury in several neurological and neurosurgical disorders commonly encountered in a neuro-intensive care unit. Corticosteroids' potent anti-inflammatory, immunomodulatory, and neuroprotective properties can potentially confer benefit in these conditions. However, despite encouraging results in preclinical studies, clinical trials show a definitive therapeutic benefit in only some of these disorders. Moreover, corticosteroids can cause serious adverse effects, especially when used in high, supraphysiological doses and for a prolonged duration. Hence, a rational and evidence-based approach is crucial for ensuring their optimal utilization in a neurocritical care setting. In this chapter, we discuss the fundamental physiological and pharmacological concepts regarding corticosteroids and investigate the evidence regarding their efficacy and safety, during the management of various critical neurological and non-neurological conditions in the neuro-intensive care unit.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85206413052&origin=inward; http://dx.doi.org/10.1007/978-981-99-8059-8_24; https://link.springer.com/10.1007/978-981-99-8059-8_24; https://dx.doi.org/10.1007/978-981-99-8059-8_24; https://link.springer.com/chapter/10.1007/978-981-99-8059-8_24
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know